PortfoliosStock ScreensStocksStockXcel

BioAtla Inc.

BCAB | US

4.91

USD

0.41

8.99%

BCAB | US

About BioAtla Inc.

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

16/04/2026

Close

4.91

Open

4.56

High

5.00

Low

4.31

BioAtla Inc. a clinical stage biopharmaceutical company develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011 a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors non-small cell lung cancer (NSCLC) and ovarian cancer. It also develops BA3021 a CAB ADC for multiple solid tumor types including NSCLC melanoma and head and neck cancer; and BA3071 which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma NSCLC small cell lung cancer hepatocellular carcinoma melanoma bladder cancer gastric cancer and cervical cancer. BioAtla Inc. was founded in 2007 and is based in San Diego California.

View Less

BCAB | US

Risk
126.3
Sharpe
-0.55
Luna's Score
52/100
Recommendation
Hold

Luna says (BCAB | US)

What's Working

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

Strong Revenue Growth (> 10%)

What's not Working

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

126.0%

1 month

126.3%

3 months

151.5%

6 months

155.0%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

2.85

Debt to equity

0.05

Debt to assets

0.02

Ent. to EBITDA

0.31

Ent. to rev.

134.37

PEG

-

Other Fundamentals

EBITDA

-108.88M

MarketCap

237.33M

MarketCap(USD)

237.33M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

31.60

Ret. on equity

-134.14

Short ratio

7.70

Short perc.

10.33

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

6.39

Range1M

6.40

Range3M

6.40

Volumes: Market Activity

Rel. volume

0.89

Price X volume

198.25K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Compugen LtdCGENBiotechnology2.89258.76M0.00%n/a5.19%
Verastem IncVSTMBiotechnology6.34255.15M0.16%n/a104.63%
Alector IncALECBiotechnology2.55248.17M-1.16%n/a23.98%
Northwest Biotherapeutics IncNWBOBiotechnology0.1971247.02M-1.45%n/a0.00%
Prelude Therapeutics IncorporatedPRLDBiotechnology4.43243.76M-19.75%n/a9.99%
Arcturus Therapeutics LtdARCTBiotechnology8.84239.05M2.55%n/a11.94%
Abeona Therapeutics IncABEOBiotechnology5.38233.03M-0.37%n/a31.63%
Anika Therapeutics IncANIKBiotechnology15.39227.72M0.72%n/a13.35%
LogicBio Therapeutics IncLOGCBiotechnology8.5223.33M-3.41%n/a0.00%
Lexeo Therapeutics Inc. Common StockLXEOBiotechnology6.58217.54M-3.24%n/a6.58%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Urban One IncUONEKBroadcasting - Radio4.87258.15M0.00%n/a268.43%
CPI Card Group IncPMTSBuilding Products & Equipment17.89199.61M1.02%15.61-621.78%
ONEWATER MARINE INC.ONEWRecreational Vehicles9.74156.39M0.72%n/a286.96%
Kewaunee Scientific CorporationKEQUBuilding Products & Equipment34.99100.48M0.63%5.1619.82%
Virco Mfg. CorporationVIRCBuilding Products & Equipment6.1299.69M0.49%9.0939.79%
Saga Communications IncSGABroadcasting - Radio11.9374.70M1.14%14.487.10%
ILAGILAGBuilding Products & Equipment3.3259.96M0.00%n/a5.48%
Beasley Broadcast Group IncBBGIBroadcasting - Radio1421.32M2.04%n/a204.46%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.61211.83M-2.84%n/a58.43%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.7410.81M6.52%0.0316.03%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA0.31-Cheaper
Ent. to Revenue134.37-Cheaper
PE Ratio-41.03-
Price to Book2.8515.55Cheaper
Dividend Yield---
Std. Deviation (3M)151.53-Riskier
Debt to Equity0.05-1.23Expensive
Debt to Assets0.020.25Cheaper
Market Cap237.33M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007